Long-Lasting Therapies with High Doses of D-chiro-inositol: The Downside
Open Access
- 3 January 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (1) , 390
Abstract
Background: Recent studies reported possible concerns following long-lasting treatments with high doses of D-chiro-inositol in women. However, to date, no clinical trial has investigated or validated these concerns. We addressed this issue both retrospectively and with a prospective pilot study. Methods: For the retrospective analysis, we searched our databases for insulin-resistant women who took 1200 mg/day D-chiro-inositol for 6 months. In our prospective study, we enrolled 10 healthy women to supplement with the same therapeutic scheme. We performed statistical analyses through the Wilcoxon Signed-Rank Test. A p-value < 0.05 was considered significant. Results: Twenty women underwent 6 months of 1200 mg/day D-chiro-inositol. The treatment significantly decreased BMI, glycemia, insulinemia, HOMA-IR, serum levels of LH, total testosterone, and DHEAS. Serum estradiol rose and menstrual abnormalities occurred following the treatment. In our prospective study, we observed increases in serum levels of total testosterone and asprosin in healthy women. Conclusions: This is the first clinical evidence demonstrating that long-term treatments with high dosages of D-chiro-inositol can predispose women to hormonal and menstrual abnormalities. Moreover, the accumulation of D-chiro-inositol following such treatment regimen may lead to detrimental effects in non-reproductive tissues, as demonstrated by the increase in asprosin levels.Keywords
This publication has 24 references indexed in Scilit:
- Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositolReproductive Biology and Endocrinology, 2016
- Asprosin, a Fasting-Induced Glucogenic Protein HormoneCell, 2016
- Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOSReproductive Sciences, 2014
- Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controlsEndocrine Journal, 2014
- The D-chiro-inositol paradox in the ovaryFertility and Sterility, 2011
- Androgen production in womenFertility and Sterility, 2002
- D‐Chiro‐Inositol – Its Functional Role in Insulin Action and its Deficit in Insulin ResistanceJournal of Diabetes Research, 2002
- Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary SyndromeNew England Journal of Medicine, 1999
- Phosphoinositol Glycan Derived Mediators and Insulin Resistance. Prospects for Diagnosis and TherapyJournal of Basic and Clinical Physiology and Pharmacology, 1998
- Insulin Stimulates Testosterone Biosynthesis by Human Thecal Cells from Women with Polycystic Ovary Syndrome by Activating Its Own Receptor and Using Inositolglycan Mediators as the Signal Transduction System1The Journal of Clinical Endocrinology & Metabolism, 1998